Alcohol worsens fatty liver, significantly increasing mortality in high-risk patients, even with moderate intake
Recent study highlights aldafermin’s ability to reverse liver cirrhosis due to fatty liver by reducing fibrosis in patients. A significant breakthrough in treatment prospects.
We analyse the latest results of the study conducted with Resmetirom for the treatment of fatty liver disease.
Statins are effective in treating cardiovascular and liver diseases, reducing risks and improving hepatic health.
The study reveals that aspirin, administered for 6 months, reduces hepatic fat, improves inflammation and fibrosis in patients with fatty liver.
We analyzed the association between fatty liver disease and heavy metal exposure.
Gilbert’s syndrome is a common condition that causes an increase in bilirubin. It may have benefits for metabolic health and longevity. It does not require specific treatment.
An exciting study published in the New England Journal of Medicine reveals encouraging results in the quest for an effective treatment for hepatic steatosis, commonly known as fatty liver.
Chronic hepatitis B affects over 250 million people worldwide and can progress to cirrhosis and liver cancer.
We analyze the effects of new drug for the treatment of fatty liver, vonarefox.